ArticleScientific reports2023

A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss.

Kylie S Chichura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.